Table 5 Counselling and administrative costs
Counselling and administrative costs | ||||
|---|---|---|---|---|
Event pathway | Labour (min–max) | Capital (min–max) | Overheads (min–max) | Total (min–max) |
1. Family history questionnaire not returned | £9 (£9–£10) | £4 (£2–£5) | £2 (£2–£3) | £16 (£14–£17) |
2. Inappropriate referral | £69 (£37–£100) | £17 (£8–£26) | £12 (£6–£18) | £98 (£51–£144) |
3. Moderate risk – breast cancer | £66 (£27–£105) | £18 (£8–£28) | £13 (£6–£20) | £97 (£40–£153) |
4. Moderate risk – colorectal cancer | £69 (£37–£100) | £17 (£8–£26) | £12 (£6–£18) | £98 (£51–£144) |
5. Moderate risk – ovarian or breast ovarian cancer | £105 (£51–£158) | £27 (£17–£37) | £20 (£11–£28) | £151 (£79–£223) |
High risk – colorectal (HNPCC) | ||||
6. Test cancer-affected relative (mutation found) and test presymptomatic patient | £1068 (£593–£1542) | £188 (£111–£265) | £139 (£99–£180) | £1396 (£803–£1988) |
7. Test cancer-affected relative (no mutation found) and do not test presymptomatic patient | £622 (£338–£906) | £119 (£70–£167) | £85 (£58–£113) | £826 (£466–£1186) |
8. Test subsequent presymptomatic members of a family with an established mutation (MLH1/ MSH2 mutation in family) | £777 (£432–£1121) | £125 (£77–£173) | £95 (£71–£120) | £997 (£579–£1415) |
9. Counsel and arrange presymptomatic care for members of a family with no established mutation | £759 (£415–£1103) | £122 (£74–£171) | £93 (£68–£118) | £975 (£557–£1392) |
High risk – colorectal (FAP) | ||||
10. Test cancer affected relative (mutation found) and test presymptomatic patient | £1068 (£593–£1542) | £188 (£111–£265) | £139 (£99–£180) | £1396 (£803–£1988) |
11. Test cancer-affected relative (no mutation found) and do not test presymptomatic patient | £622 (£338–£906) | £119 (£70–£167) | £85 (£58–£113) | £826 (£466–£1186) |
12. Test subsequent presymptomatic members of a family with an established mutation (using linkage testing) | £777 (£432–£1121) | £125 (£77–£173) | £95 (£71–£120) | £997 (£579–£1415) |
13. Test subsequent presymptomatic members of a family with an established mutation (using sequence analysis) | £777 (£432–£1121) | £125 (£77–£173) | £95 (£71–£120) | £997 (£579–£1415) |
14. Counsel and arrange presymptomatic care for members of a family with no established mutation | £759 (£415–£1103) | £122 (£74–£171) | £93 (£68–£118) | £975 (£557–£1392) |
High risk – breast (BRCA1/2) | ||||
15. Test cancer-affected relative (mutation found) and test presymptomatic patient | £705 (£264–£1146) | £181 (£106–£256) | £110 (£67–£153) | £996 (£437–£1555) |
16. Test cancer-affected relative (no mutation found) and do not test presymptomatic patient | £430 (£173–£687) | £115 (£68–£162) | £70 (£42–£98) | £614 (£283–£946) |
17. Test subsequent presymptomatic members of a family with an established mutation | £496 (£170–£822) | £119 (£73–£166) | £72 (£45–£99) | £688 (£288–£1087) |
18. Counsel and arrange presymptomatic care for members of a family with no established mutation | £487 (£165–£809) | £117 (£70–£164) | £71 (£44–£98) | £675 (£279–£1070) |
High risk – ovarian or breast ovarian (BRCA1/2) | ||||
19. Test cancer-affected relative (mutation found) and test presymptomatic patient | £1068 (£593–£1542) | £188 (£111–£265) | £139 (££99–£180) | £1396 (£803–£1988) |
20. Test cancer-affected relative (no mutation found) and do not test presymptomatic patient | £622 (£338–£906) | £119 (£70–£167) | £85 (£58–£113) | £826 (£466–£1186) |
21. Test subsequent presymptomatic members of a family with an established mutation | £777 (£432–£1121) | £125 (£77–£173) | £95 (£71–£120) | £997 (£579–£1415) |
22. Counsel and arrange presymptomatic care for members of a family with no established mutation | £759 (£415–£1103) | £122 (£74–£171) | £93 (£68–£118) | £975 (£557–£1392) |
